Cargando…
CMBs carrying PTX and CRISPR/Cas9 targeting C-erbB-2 plasmids interfere with endometrial cancer cells
Development of combination therapy to decrease side effects of chemotherapeutic drugs and increase their utilization rate in combination with gene editing is a key research topic in tumor treatment. The present study aimed to investigate the effect of cationic microbubbles (CMBs) carrying paclitaxel...
Autores principales: | Peng, Siyuan, Cai, Junhong, Bao, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503745/ https://www.ncbi.nlm.nih.gov/pubmed/34590151 http://dx.doi.org/10.3892/mmr.2021.12470 |
Ejemplares similares
-
Effect of CMB Carrying PTX and CRISPR/Cas9 on Endometrial Cancer Naked Mouse Model
por: Cai, Junhong, et al.
Publicado: (2022) -
Ultrasound microbubble-mediated CRISPR/Cas9 knockout of C-erbB-2 in HEC-1A cells
por: Cai, Junhong, et al.
Publicado: (2019) -
Retracted: Effect of CMB Carrying PTX and CRISPR/Cas9 on Endometrial Cancer Naked Mouse Model
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis
por: Elmore, Joshua R., et al.
Publicado: (2013) -
Expression of MIF and c-erbB-2 in endometrial cancer
por: XIAO, WEI, et al.
Publicado: (2016)